Biotech · Public company · Covina, CA, US
Apollomics Inc.
Ticker APLM · SEC CIK 0001944885
Track this companyFree. Adds Apollomics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- APL-101 Oral CapsulesPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 18, 2022ClinicalTrials.gov NCT04743505 · fetched Nov 12, 2026
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · RECRUITING · started Sep 27, 2017ClinicalTrials.gov NCT03175224 · fetched Nov 12, 2026
SEC filings12
- 6-K · 6-KSEC EDGAR · filed Nov 6, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Jul 21, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Jul 14, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Jun 24, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Apr 27, 2026 · fetched Nov 12, 2026
- 20-F · 20-FSEC EDGAR · filed Apr 24, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Apr 1, 2026 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Dec 22, 2025 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Dec 12, 2025 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Nov 19, 2025 · fetched Nov 12, 2026
- 6-K · 6-KSEC EDGAR · filed Nov 18, 2025 · fetched Nov 12, 2026